Consultation open on the revision of GMP’s Chapter 1

Comments on the draft revision of Chapter 1 of the Good Manufacturing Practices must be submitted by 3 December 2025. The revision aims to update this fundamental text in light of the more recent advancements in pharmaceutical manufacturing, so to better ensure the ef-fectiveness and safety of medicinal products. The EIPG will liaise with member associations to submit a joint response to the draft text.

Steps towards the new Pharma package and the EU Startup and Scaleup Strategy

In recent weeks, important steps have been taken towards the final adoption of the new European General Pharmaceutical Legislation, with the adoption of the Council’s position preliminar to the Trilogue discussions. The Commission also presented its new strategy to support European startups and scaleups, which are fundamental to improving innovation and European competitiveness

The EU’s Competitiveness Compass and the new EU Biotech Hub

The Competitiveness Compass describes the new European Commission’s political actions to fill the gap with international competitors, support the transition to clean and digital technologies, and reduce supply chains’ dependencies in strategic sectors. Among these are also biotechnologies and more extensively, life sciences.